277 Shares in Molina Healthcare, Inc. (NYSE:MOH) Purchased by Headlands Technologies LLC

Headlands Technologies LLC bought a new stake in Molina Healthcare, Inc. (NYSE:MOHFree Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 277 shares of the company’s stock, valued at approximately $91,000.

A number of other large investors also recently made changes to their positions in the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Molina Healthcare by 15.3% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,722 shares of the company’s stock worth $3,844,000 after purchasing an additional 1,554 shares during the period. UBS Group AG boosted its position in shares of Molina Healthcare by 17.0% in the third quarter. UBS Group AG now owns 82,633 shares of the company’s stock valued at $27,095,000 after acquiring an additional 12,034 shares during the period. Aptus Capital Advisors LLC boosted its position in shares of Molina Healthcare by 5.0% in the third quarter. Aptus Capital Advisors LLC now owns 763 shares of the company’s stock valued at $250,000 after acquiring an additional 36 shares during the period. Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of Molina Healthcare in the third quarter valued at approximately $30,000. Finally, HighTower Advisors LLC boosted its position in shares of Molina Healthcare by 12.9% in the third quarter. HighTower Advisors LLC now owns 5,787 shares of the company’s stock valued at $1,910,000 after acquiring an additional 659 shares during the period. Institutional investors and hedge funds own 98.11% of the company’s stock.

Molina Healthcare Stock Performance

Shares of NYSE:MOH opened at $392.66 on Tuesday. Molina Healthcare, Inc. has a twelve month low of $256.19 and a twelve month high of $393.34. The firm has a market cap of $22.89 billion, a PE ratio of 20.91, a price-to-earnings-growth ratio of 1.12 and a beta of 0.45. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.47 and a current ratio of 1.54. The business has a fifty day moving average of $367.83 and a 200-day moving average of $345.70.

Molina Healthcare (NYSE:MOHGet Free Report) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.31 by $0.07. The business had revenue of $9.05 billion for the quarter, compared to analysts’ expectations of $8.35 billion. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business earned $4.10 earnings per share. On average, equities research analysts predict that Molina Healthcare, Inc. will post 23.55 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Ronna Romney sold 335 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $358.00, for a total value of $119,930.00. Following the transaction, the director now owns 16,907 shares in the company, valued at $6,052,706. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. UBS Group raised their target price on Molina Healthcare from $350.00 to $380.00 and gave the stock a “neutral” rating in a research report on Thursday, December 21st. Cantor Fitzgerald increased their price objective on Molina Healthcare from $374.00 to $406.00 and gave the stock an “overweight” rating in a research note on Friday. StockNews.com lowered Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 8th. Finally, JPMorgan Chase & Co. increased their price objective on Molina Healthcare from $367.00 to $392.00 and gave the stock an “overweight” rating in a research note on Friday, November 17th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $357.50.

Read Our Latest Research Report on MOH

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.